102 related articles for article (PubMed ID: 19759547)
1. Impact of NAD(P)H:quinone oxidoreductase-1 on pigmentation.
Choi TY; Sohn KC; Kim JH; Kim SM; Kim CH; Hwang JS; Lee JH; Kim CD; Yoon TJ
J Invest Dermatol; 2010 Mar; 130(3):784-92. PubMed ID: 19759547
[TBL] [Abstract][Full Text] [Related]
2. NADPH:quinone oxidoreductase-1 as a new regulatory enzyme that increases melanin synthesis.
Yamaguchi Y; Hearing VJ; Maeda A; Morita A
J Invest Dermatol; 2010 Mar; 130(3):645-7. PubMed ID: 20145642
[TBL] [Abstract][Full Text] [Related]
3. Regulation of pigmentation by substrate elasticity in normal human melanocytes and melanotic MNT1 human melanoma cells.
Choi H; Kim M; Ahn SI; Cho EG; Lee TR; Shin JH
Exp Dermatol; 2014 Mar; 23(3):172-7. PubMed ID: 24517137
[TBL] [Abstract][Full Text] [Related]
4. The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells.
Garate M; Wani AA; Li G
Free Radic Biol Med; 2010 Jun; 48(12):1601-9. PubMed ID: 20226854
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H dehydrogenase, quinone 1 (NQO1), protects melanin-producing cells from cytotoxicity of rhododendrol.
Okubo A; Yasuhira S; Shibazaki M; Takahashi K; Akasaka T; Masuda T; Maesawa C
Pigment Cell Melanoma Res; 2016 May; 29(3):309-16. PubMed ID: 26847926
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of melanin synthesis by cystamine in human melanoma cells.
Qiu L; Zhang M; Sturm RA; Gardiner B; Tonks I; Kay G; Parsons PG
J Invest Dermatol; 2000 Jan; 114(1):21-7. PubMed ID: 10620110
[TBL] [Abstract][Full Text] [Related]
7. Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition.
Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
Cancer Res; 2005 Nov; 65(21):10006-15. PubMed ID: 16267026
[TBL] [Abstract][Full Text] [Related]
8. Neural stem cells inhibit melanin production by activation of Wnt inhibitors.
Hwang I; Park JH; Park HS; Choi KA; Seol KC; Oh SI; Kang S; Hong S
J Dermatol Sci; 2013 Dec; 72(3):274-83. PubMed ID: 24016750
[TBL] [Abstract][Full Text] [Related]
9. Biochemical, cytotoxic, and genotoxic effects of ES936, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, in cellular systems.
Dehn DL; Siegel D; Swann E; Moody CJ; Ross D
Mol Pharmacol; 2003 Sep; 64(3):714-20. PubMed ID: 12920209
[TBL] [Abstract][Full Text] [Related]
10. Alcohol extract from Vernonia anthelmintica (L.) willd seed enhances melanin synthesis through activation of the p38 MAPK signaling pathway in B16F10 cells and primary melanocytes.
Zhou J; Shang J; Ping F; Zhao G
J Ethnopharmacol; 2012 Sep; 143(2):639-47. PubMed ID: 22867636
[TBL] [Abstract][Full Text] [Related]
11. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
12. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
13. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase.
Siemankowski LM; Morreale J; Butts BD; Briehl MM
Cancer Res; 2000 Jul; 60(13):3638-44. PubMed ID: 10910079
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.
Slominski A; Zbytek B; Slominski R
Int J Cancer; 2009 Mar; 124(6):1470-7. PubMed ID: 19085934
[TBL] [Abstract][Full Text] [Related]
15. Expression of melanin-related genes in cultured adult human retinal pigment epithelium and uveal melanoma cells.
Lu F; Yan D; Zhou X; Hu DN; Qu J
Mol Vis; 2007 Nov; 13():2066-72. PubMed ID: 18079680
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of melanoblast pigmentation by 8-methoxypsoralen:the involvement of microphthalmia-associated transcription factor, the protein kinase a signal pathway, and proteasome-mediated degradation.
Lei TC; Virador V; Yasumoto K; Vieira WD; Toyofuku K; Hearing VJ
J Invest Dermatol; 2002 Dec; 119(6):1341-9. PubMed ID: 12485437
[TBL] [Abstract][Full Text] [Related]
17. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
[TBL] [Abstract][Full Text] [Related]
18. β-Cryptoxanthin suppresses UVB-induced melanogenesis in mouse: involvement of the inhibition of prostaglandin E2 and melanocyte-stimulating hormone pathways.
Shimoda H; Shan SJ; Tanaka J; Maoka T
J Pharm Pharmacol; 2012 Aug; 64(8):1165-76. PubMed ID: 22775220
[TBL] [Abstract][Full Text] [Related]
19. The expression of NAD(P)H:quinone oxidoreductase 1 is increased along with NF-kappaB p105/p50 in human cutaneous melanomas.
Cheng Y; Li J; Martinka M; Li G
Oncol Rep; 2010 Apr; 23(4):973-9. PubMed ID: 20204281
[TBL] [Abstract][Full Text] [Related]
20. Acanthoic acid inhibits melanogenesis through tyrosinase downregulation and melanogenic gene expression in B16 melanoma cells.
Yoon WJ; Ham YM; Yoon HS; Lee WJ; Lee NH; Hyun CG
Nat Prod Commun; 2013 Oct; 8(10):1359-62. PubMed ID: 24354173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
